ClinicalTrials.gg
CompletedNCT01554527Updated Jan 14, 2019Results posted

Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children

An interventional study of CPAP treatment and No CPAP treatment in Sleep Apnea, Obstructive, Sleep Apnea Syndromes and Child Behavior Disorders, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2019-01-14.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
5 Years to 12 Years
Sex
All
01

Study summary

Obstructive sleep-disordered breathing (SDB) affects 2-3% of children and may lead to problems with nighttime sleep and daytime behavior, learning, sleepiness, and mood. Adenotonsillectomy (AT) is the second most common surgical procedure in children. It is now performed more often for suspected SDB than for any other indication. However, recent studies indicate that many if not most children still have SDB after AT, and many still have learning or behavioral problems associated with SDB. The goals of this study are: (1) to assess the extent that behavior, cognition, and sleepiness in children can improve with Continuous positive airway pressure (CPAP) treatment after AT, and (2) to identify which patients stand to gain most from post-operative assessment and treatment.

Read the detailed description

Obstructive sleep-disordered breathing (SDB) affects at least 2-3% of children and may have substantial adverse impact on behavior and cognition. Adenotonsillectomy (AT), the second most common surgical procedure in children, is now performed more often for suspected SDB than for any other indication. However, recent studies among an increasingly obese population now show something alarming: many if not most children still have SDB after AT, and many still suffer from residual neurobehavioral morbidity. Furthermore, the investigators' ongoing, 12-year, NIH-funded research has shown that standard preoperative polysomnographic measures of SDB do not consistently predict post-AT improvement in behavior and cognition. This may arise in part because many children after AT still have SDB, and because linear relationships between standard SDB measures and neurobehavioral morbidity may not exist. Even at subtle levels, SDB may promote significant neurobehavioral morbidity. Some have suggested that polysomnography may be more important after AT than before AT. However, in practice few children receive polysomnography before AT, and even fewer after AT, when continuous positive airway pressure (CPAP) could still provide definitive relief from SDB. Preliminary data from our group suggest that CPAP after AT is well-tolerated by most children and may provide significant benefit. However, virtually no published evidence exists to address critical clinical questions: which children benefit most from CPAP after AT; what role can clinical symptoms or polysomnography play in that determination; and what neurobehavioral gains are achieved by CPAP after AT?

The investigators therefore will undertake a highly practical, clinical study with two main goals: (1) to assess the extent that behavior, cognition, and sleepiness in children can improve with CPAP after AT, and (2) to identify which patients stand to gain most from post-operative assessment and treatment. This research will use reversible SDB-related neurobehavioral morbidity as the criteria by which to judge the utility of clinical symptoms and polysomnography in identification of candidates for CPAP after AT.

02

Conditions studied

  • Sleep Apnea, Obstructive
  • Sleep Apnea Syndromes
  • Child Behavior Disorders
  • Attention Deficit Disorder With Hyperactivity
  • Disorders of Excessive Somnolence

Keywords

  • polysomnography
  • child
  • continuous positive airway pressure
  • tonsillectomy
  • neuropsychological tests
  • cognition
  • sleepiness
  • behavior
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's enrollment of 120 is above the median of 52 across 1,472 interventional studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,506 studies on the registry; 192 are open to participants now.

Of its 169 completed or terminated interventional studies of FDA-regulated products, 133 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children ages 5-12 years old,
  2. Scheduled for an adenotonsillectomy for treatment of sleep apnea,
  3. Child must provide assent, and
  4. Parent or legal guardian must be able to speak and read English, and agree to the study.

Exclusion criteria

Exclusion Criteria:

  1. No siblings of children already enrolled in the study,
  2. Children who expect to have another surgery (in addition to AT) during the period of participation in this study,
  3. Neurological, psychiatric, or medical conditions, or social factors that may affect test results, prevent children from returning for required study visits, or interfere with the study treatment, or
  4. Certain medications that affect sleepiness or alertness, for example:

    • Stimulants (such as Ritalin, Adderall, or Concerta),
    • Sleep aides (such as Melatonin, Ambien, or Ativan), or
    • Sedating medicines (such as Benadryl, Klonopin, Xanax, or Valerian).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    CPAP treatment

    Children randomized to this arm will receive 6 months of CPAP (or BPAP) treatment, beginning at approximately 4 months after AT, in addition to standard of care. For analysis purposes those children who were non-adherent (CPAP use \<4 hours per night) vs. adherent (CPAP use at least 4 hours per night) will be analyzed separately.

    Procedure: CPAP treatment

  • Other
    No CPAP treatment

    Children randomized to this comparison arm will not be treated with CPAP or BPAP, but will be followed for approximately 10 months after AT while receiving standard of care.

    Other: No CPAP treatment

Interventions

  • ProcedureCPAP treatment

    6 months of treatment with PAP (CPAP or BPAP)

    Also known as: Continuous positive airway pressure device (CPAP), Bi-level positive airway pressure device (BPAP), Positive Airway Pressure device (PAP)

  • OtherNo CPAP treatment

    Children randomized to the comparison group will receive routine care

    Also known as: Comparison group, Control group

06

What researchers measure

Primary outcomes

  1. Change in Behavioral Index After 6 Months of CPAP or No-CPAP

    The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of "\<10" to "\>90" - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.

    Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Secondary outcomes

  1. Change in Cognition as Shown by NIH Toolbox Composite Score

    Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better

    Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

  2. Change in Sleepiness as Measured by Epworth Sleepiness Scale

    Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.

    Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

  3. Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)

    Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.

    Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

  4. Change in Quality of Life as Measured by Peds QL

    Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life

    Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

  5. CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.

    CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.

    Time frame: Starting at 4 months after AT and continuing through 10 months after AT

Other outcomes

  1. Change in Cognition as Measured by Fluid Cognition Scores

    Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better

    Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

  2. Change in Cognition After AT as Shown by Academic Achievement

    Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better

    Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

07

Results

Posted Jan 14, 2019

Participant flow

Of 120 consented, 105 were randomized to CPAP or control. (Of the 15 who weren't randomized, 8 were lost to follow up; the other withdrew for various reasons)

Participant flow — Overall Study
MilestoneControl Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)
Started343833
Crossed over to control002
Had cpap titration03830
Initiated cpap treatment at home03828
Completed as a control3301
Completed333825
Not completed108
Withdrew: Withdrawal by subject103
Withdrew: Lost to follow-up004
Withdrew: Physician decision001

Outcome measures

PrimaryChange in Behavioral Index After 6 Months of CPAP or No-CPAP

The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of "\<10" to "\>90" - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.

Time frame:
assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Reported as:
Mean · T score
Change in Behavioral Index After 6 Months of CPAP or No-CPAP
T scoreControl Group (Surgery Only - no CPAP)CPAP After Surgery (Non-adherent)CPAP After Surgery (Adherent)
Change in Behavioral Index After 6 Months of CPAP or No-CPAP-2.7 ± 5.8.9 ± 4.8-1.2 ± 6.3
Statistical analysis
  • Control Group (Surgery Only - no CPAP) vs CPAP After Surgery (Non-adherent) vs CPAP After Surgery (Adherent) · t-test, 2 sided · p = 0.07
SecondaryChange in Cognition as Shown by NIH Toolbox Composite Score

Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better

Time frame:
assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Reported as:
Mean · score on a scale
Change in Cognition as Shown by NIH Toolbox Composite Score
score on a scaleControl Group (Surgery Only - no CPAP)CPAP After Surgery (Non-adherent)CPAP After Surgery (Adherent)
Change in Cognition as Shown by NIH Toolbox Composite Score5.5 ± 9.52.8 ± 9.83.9 ± 7.8
Statistical analysis
  • Control Group (Surgery Only - no CPAP) vs CPAP After Surgery (Non-adherent) vs CPAP After Surgery (Adherent) · t-test, 2 sided · p = 0.34
SecondaryChange in Sleepiness as Measured by Epworth Sleepiness Scale

Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.

Time frame:
assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Reported as:
Mean · score on a scale
Change in Sleepiness as Measured by Epworth Sleepiness Scale
score on a scaleControl Group (Surgery Only - no CPAP)CPAP After Surgery (Non-adherent)CPAP After Surgery (Adherent)
Change in Sleepiness as Measured by Epworth Sleepiness Scale-1.6 ± 3.7-1.0 ± 2.2-1.9 ± 3.8
Statistical analysis
  • Control Group (Surgery Only - no CPAP) vs CPAP After Surgery (Non-adherent) vs CPAP After Surgery (Adherent) · t-test, 2 sided · p = 0.93
SecondaryChange in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)

Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.

Time frame:
assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Reported as:
Mean · minutes
Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)
minutesControl Group (Surgery Only - no CPAP)CPAP After Surgery (Non-adherent)CPAP After Surgery (Adherent)
Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)-1.8 ± 4-1.3 ± 5.1-1.1 ± 4.3
Statistical analysis
  • Control Group (Surgery Only - no CPAP) vs CPAP After Surgery (Non-adherent) vs CPAP After Surgery (Adherent) · t-test, 2 sided · p = 0.5
SecondaryChange in Quality of Life as Measured by Peds QL

Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life

Time frame:
assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Reported as:
Mean · score on a scale
Change in Quality of Life as Measured by Peds QL
score on a scaleControl Group (Surgery Only - no CPAP)CPAP After Surgery (Non-adherent)CPAP After Surgery (Adherent)
Change in Quality of Life as Measured by Peds QL4.1 ± 9.00.5 ± 10.22.4 ± 12.1
Statistical analysis
  • Control Group (Surgery Only - no CPAP) vs CPAP After Surgery (Non-adherent) vs CPAP After Surgery (Adherent) · t-test, 2 sided · p = 0.25
SecondaryCPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.

CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.

Time frame:
Starting at 4 months after AT and continuing through 10 months after AT
Reported as:
Count of participants · Participants
CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.
ParticipantsCPAP Group
CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.38
Other pre-specifiedChange in Cognition as Measured by Fluid Cognition Scores

Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better

Time frame:
assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Reported as:
Mean · score on a scale
Change in Cognition as Measured by Fluid Cognition Scores
score on a scaleControl Group (Surgery Only - no CPAP)CPAP After Surgery (Non-adherent)CPAP After Surgery (Adherent)
Change in Cognition as Measured by Fluid Cognition Scores6.7 ± 12.41.7 ± 11.53.4 ± 10.1
Other pre-specifiedChange in Cognition After AT as Shown by Academic Achievement

Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better

Time frame:
assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Reported as:
Mean · units on a scale
Change in Cognition After AT as Shown by Academic Achievement
units on a scaleControl Group (Surgery Only - no CPAP)CPAP After Surgery (Non-adherent)CPAP After Surgery (Adherent)
Change in Cognition After AT as Shown by Academic Achievement-1.0 ± 5.61.1 ± 4.7-2.5 ± 8.6

Adverse events

Collected over Adverse events were followed from consent (which could be before surgery or after surgery) until 10 months after surgery equating to six months after assignment.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
CPAP Treatment Group on CPAP0/69 (0%)6/69 (8.7%)59/69 (85.5%)
No CPAP Treatment Group0/36 (0%)7/36 (19.4%)26/36 (72.2%)
Non-randomized Participants0/15 (0%)4/15 (26.7%)7/15 (46.7%)
Most frequent serious events
Most frequent serious events
EventCPAP Treatment Group on CPAPNo CPAP Treatment GroupNon-randomized Participants
Post-operative hospitalizationSurgical and medical procedures4/697/364/15
Hospitalization for ashthmaRespiratory, thoracic and mediastinal disorders1/690/360/15
ER admission due to panic attackPsychiatric disorders1/690/360/15
Most frequent other events
Showing 10 of 22
Most frequent other events
EventCPAP Treatment Group on CPAPNo CPAP Treatment GroupNon-randomized Participants
Skin IrritationSkin and subcutaneous tissue disorders42/6912/360/15
Cold SymptomsGeneral disorders38/6916/362/15
Unrelated AccidentInjury, poisoning and procedural complications22/699/361/15
Asthma ExacerbationRespiratory, thoracic and mediastinal disorders17/695/360/15
AnxietyPsychiatric disorders12/698/360/15
Stomach FluGastrointestinal disorders14/695/360/15
Upper Respiratory InfectionInfections and infestations7/696/362/15
Behavior IssuesSocial circumstances11/694/360/15
Allergic ReactionImmune system disorders8/695/360/15
Life Event or ChangeSocial circumstances2/695/361/15

Baseline characteristics

Age, Continuous
Age, Continuous(years)Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
Mean7.9 ± 2.08.3 ± 2.28.0 ± 2.08.1 ± 2.1
Sex: Female, Male
Sex: Female, Male(Participants)Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
Female13211650
Male21171755
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
Hispanic or Latino5207
Not Hispanic or Latino29363398
Unknown or Not Reported0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
American Indian or Alaska Native0000
Asian1113
Native Hawaiian or Other Pacific Islander0000
Black or African American15814
White28291976
More than one race43512
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(Participants)Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
United States343833105
Behavioral Index
Behavioral Index(units on a scale (T-Score))Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
Mean61.6 ± 13.456.5 ± 11.357.8 ± 11.658.5 ± 12.1
NIH Toolbox Age adjusted composite score
NIH Toolbox Age adjusted composite score(units on a scale)Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
Mean95.7 ± 11.996.2 ± 12.393.9 ± 11.695.1 ± 11.6
Epworth Sleepiness Scale
Epworth Sleepiness Scale(units on a scale)Control Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)Total
Mean7.2 ± 4.66.9 ± 3.96.4 ± 3.06.8 ± 3.9

6 further baseline measures are reported on the registry.

08

Study locations

1 site
  • University of Michigan Health System
    Ann Arbor, Michigan 48109, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01554527
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), Michigan Technological University
Responsible party
Ronald D. Chervin, M.D., M.S. (Professor of Neurology, University of Michigan) — Principal investigator
First posted
Mar 15, 2012
Start date
Mar 2012
Primary completion
Oct 29, 2017
Completion
Oct 29, 2017
Results posted
Jan 14, 2019
Last update
Jan 14, 2019

Study contacts

Ronald D. Chervin, MD, MS
principal investigator · University of Michigan

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion